Prosecution Insights
Last updated: May 29, 2026
Application No. 17/498,020

FLOW CYTOMETER AND METHOD OF FLOW CYTOMETRY

Non-Final OA §102
Filed
Oct 11, 2021
Priority
Oct 23, 2020 — EU 20203563.0
Examiner
LAPAGE, MICHAEL P
Art Unit
2877
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Sysmex Corporation
OA Round
3 (Non-Final)
79%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
612 granted / 777 resolved
+10.8% vs TC avg
Strong +34% interview lift
Without
With
+34.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
30 currently pending
Career history
809
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
79.0%
+39.0% vs TC avg
§102
5.7%
-34.3% vs TC avg
§112
13.8%
-26.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 777 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 03/23/2026 has been entered. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1, 24 and 25 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Van Den Engh (U.S. PGPub No. 2021/0123854 A1). As to claims 1 and 24, Van Den Engh discloses and shows in figures 3 and 4, a flow cytometer, comprising: a flow cell (210) defining a flow channel (216) for flowing a liquid containing a particle (220) through the flow cell, a flow direction of the particles through the channel being on a YZ plane and a XY plane perpendicular to the YZ plane (the planes as claimed can be explicitly drawn through the figures 3/4) ([0024], ll. 1-10); a light source (212) arranged to emit light to a single particle at a time (explicitly shown via beam diameter in figure 3) flowing through the channel, the light being incident to the particle at an incidence angle inclined to a normal direction (explicitly shown in figures 3/4, θ) with respect to a flow direction of the particle through the channel (i.e. along axis A2) at the interrogation point, the light being on the YZ plane and the normal direction being on a XZ plane perpendicular to the YZ plane and the XY plane (again the planes as define by applicant are taught by the figures) ([0024], ll. 1-11; [0025], ll. 1-5); and a plurality of light detectors (322a and 322b) arranged around the flow cell and arranged for receiving light diverging from the particle (i.e. scatter detection) ([0028]). wherein each of the plurality of light detectors is arranged without a lens between each light detector and the flow cell, and no element with optical power is arranged between the flow cell and each of the plurality of light detectors ([0028]; as disclosed the only optical element present is aperture 326a/b which are not disclosed as having any optical power). The subject matter of claims 1 and 24 relate in that the technical features of apparatus claim 1 are in each case suitable for implementing the method of claim 24, therefore the method is inherent, in view of the above apparatus rejection. As to claim 25, Van Den Engh discloses and shows in figure 4 a flow cytometer, wherein the plurality of light detectors comprises at least three light detectors ([0028]; as disclosed up to 6 detectors can be placed around the intercept point). Response to Arguments Applicant’s arguments with respect to claim(s) 1, 24 and 25 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Prior art made of record Kay et al. (U.S. Patent No. 4,293,221) explicitly also shows using a beam profile designed to illuminate one particle at a time in figure 2. Padmanabhan et al. (U.S. PGPub No. 2005/0118723 A1) shows in figure 20 the focusing of light to illuminate one particle 512 at a time in figure 20. Gu et al. (U.S. PGPub No. 2007/0190525 A1) appears to discloses and shows all the features of claims 1, 24 in figure 11. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL P LAPAGE whose telephone number is (571)270-3833. The examiner can normally be reached Monday-Friday 8-5:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Tarifur Chowdhury can be reached on 571-272-2287. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Michael P LaPage/Primary Examiner, Art Unit 2877
Read full office action

Prosecution Timeline

Oct 11, 2021
Application Filed
Apr 21, 2025
Non-Final Rejection mailed — §102
Oct 21, 2025
Response Filed
Nov 24, 2025
Final Rejection mailed — §102
Feb 24, 2026
Response after Non-Final Action
Mar 23, 2026
Request for Continued Examination
Mar 26, 2026
Response after Non-Final Action
Mar 30, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12638781
AUTOMATED METROLOGY METHOD FOR LARGE DEVICES
2y 11m to grant Granted May 26, 2026
Patent 12631973
OVERLAY MEASUREMENT STRUCTURES HAVING OVERLAPPING PATTERNS
4y 3m to grant Granted May 19, 2026
Patent 12602760
METHOD AND APPARATUS FOR DETECTING DEFECT BASED ON PHASED PASS/FAIL DETERMINATION
3y 7m to grant Granted Apr 14, 2026
Patent 12601676
REMOVABLE CIRCULAR NOZZLE FOR FLOW CYTOMETERS
2y 5m to grant Granted Apr 14, 2026
Patent 12601671
Particle Size Statistical Method of Granular Minerals of Shale
2y 5m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
79%
Grant Probability
99%
With Interview (+34.2%)
2y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 777 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month